Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment-Reference-Cited by-同舟云学术

Advances in genome editing: the technology of choice for precise and efficient β-thalassemia treatment

Published:2020-04-30 Issue:1-2 Volume:28 Page:6-15
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Ali Gibran,Tariq Muhammad Akram,Shahid Kamran,Ahmad Fridoon Jawad,Akram Javed

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/s41434-020-0153-9.pdf

Reference88 articles.

1. Weatherall D, Akinyanju O, Fucharoen S, Olivieri N, Musgrove P. Inherited disorders of hemoglobin. Oxford University Press. 2006; Chapter 34.

2. Cousens NE, Gaff CL, Metcalfe SA, Delatycki MB. Carrier screening for beta-thalassaemia: a review of international practice. Eur J Hum Genet. 2010;18:1077–83.

3. Manzoor I, Zakar R. Sociodemographic determinants associated with parental knowledge of screening services for thalassemia major in Lahore. Pak J Med Sci. 2019;35:483–8.

4. Weatherall DJ. Thalassaemia: the long road from bedside to genome. Nat Rev Genet. 2004;5:625–31.

5. Yasmeen H, Hasnain S. Epidemiology and risk factors of transfusion transmitted infections in thalassemia major: a multicenter study in Pakistan. Hematol Transfus Cell Ther. 2019;41:316–23.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bone marrow Tfr2 deletion improves the therapeutic efficacy of the activin‐receptor ligand trap RAP‐536 in β‐thalassemic mice;American Journal of Hematology;2024-04-17

2. Cellular and animal models for the investigation of β-thalassemia;Blood Cells, Molecules, and Diseases;2024-01

3. Molecular Marvels: Small Molecules Paving the Way for Enhanced Gene Therapy;Pharmaceuticals;2023-12-27

4. Applications and Research Advances in the Delivery of CRISPR/Cas9 Systems for the Treatment of Inherited Diseases;International Journal of Molecular Sciences;2023-08-25

5. Combined approaches for increasing fetal hemoglobin (HbF) and de novo production of adult hemoglobin (HbA) in erythroid cells from β-thalassemia patients: treatment with HbF inducers and CRISPR-Cas9 based genome editing;Frontiers in Genome Editing;2023-07-17